ALLSTATE CORP (ALL) Stock Fundamental Analysis

NYSE:ALL • US0200021014

211.55 USD
+2.22 (+1.06%)
Last: Feb 26, 2026, 12:46 PM
Fundamental Rating

4

Taking everything into account, ALL scores 4 out of 10 in our fundamental rating. ALL was compared to 150 industry peers in the Insurance industry. ALL has an average financial health and profitability rating. ALL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ALL was profitable.
  • In the past year ALL had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALL reported negative net income in multiple years.
  • Of the past 5 years ALL 4 years had a positive operating cash flow.
ALL Yearly Net Income VS EBIT VS OCF VS FCFALL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.86%, ALL belongs to the top of the industry, outperforming 90.67% of the companies in the same industry.
  • The Return On Equity of ALL (30.03%) is better than 96.00% of its industry peers.
Industry RankSector Rank
ROA 6.86%
ROE 30.03%
ROIC N/A
ROA(3y)4.09%
ROA(5y)2.46%
ROE(3y)17.55%
ROE(5y)10.09%
ROIC(3y)N/A
ROIC(5y)N/A
ALL Yearly ROA, ROE, ROICALL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • ALL has a Profit Margin of 12.36%. This is in the better half of the industry: ALL outperforms 68.00% of its industry peers.
  • ALL's Profit Margin has improved in the last couple of years.
  • ALL has a Operating Margin of 14.27%. This is comparable to the rest of the industry: ALL outperforms 60.00% of its industry peers.
  • ALL's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.27%
PM (TTM) 12.36%
GM N/A
OM growth 3YN/A
OM growth 5Y-2.22%
PM growth 3YN/A
PM growth 5Y2.88%
GM growth 3YN/A
GM growth 5YN/A
ALL Yearly Profit, Operating, Gross MarginsALL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

4

2. Health

2.1 Basic Checks

  • ALL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALL has been reduced compared to 1 year ago.
  • The number of shares outstanding for ALL has been reduced compared to 5 years ago.
  • ALL has a better debt/assets ratio than last year.
ALL Yearly Shares OutstandingALL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ALL Yearly Total Debt VS Total AssetsALL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • ALL has a debt to FCF ratio of 0.94. This is a very positive value and a sign of high solvency as it would only need 0.94 years to pay back of all of its debts.
  • The Debt to FCF ratio of ALL (0.94) is better than 71.33% of its industry peers.
  • A Debt/Equity ratio of 0.29 indicates that ALL is not too dependend on debt financing.
  • ALL has a Debt to Equity ratio (0.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 0.94
Altman-Z N/A
ROIC/WACCN/A
WACC8.07%
ALL Yearly LT Debt VS Equity VS FCFALL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ALL Yearly Current Assets VS Current LiabilitesALL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 90.78% over the past year.
  • ALL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.73% yearly.
  • ALL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.58%.
  • The Revenue has been growing by 10.06% on average over the past years. This is quite good.
EPS 1Y (TTM)90.78%
EPS 3YN/A
EPS 5Y18.73%
EPS Q2Q%86.57%
Revenue 1Y (TTM)5.58%
Revenue growth 3Y9.6%
Revenue growth 5Y10.06%
Sales Q2Q%5.92%

3.2 Future

  • The Earnings Per Share is expected to decrease by -15.80% on average over the next years. This is quite bad
  • ALL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.94% yearly.
EPS Next Y-29.66%
EPS Next 2Y-15.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.73%
Revenue Next 2Y5.84%
Revenue Next 3Y8.67%
Revenue Next 5Y6.94%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALL Yearly Revenue VS EstimatesALL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
ALL Yearly EPS VS EstimatesALL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 6.05 indicates a rather cheap valuation of ALL.
  • Based on the Price/Earnings ratio, ALL is valued cheaply inside the industry as 81.33% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.05, ALL is valued rather cheaply.
  • ALL is valuated reasonably with a Price/Forward Earnings ratio of 8.61.
  • ALL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALL is cheaper than 65.33% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ALL to the average of the S&P500 Index (28.03), we can say ALL is valued rather cheaply.
Industry RankSector Rank
PE 6.05
Fwd PE 8.61
ALL Price Earnings VS Forward Price EarningsALL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 72.00% of the companies in the same industry are more expensive than ALL, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALL indicates a somewhat cheap valuation: ALL is cheaper than 63.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.37
EV/EBITDA 6.12
ALL Per share dataALL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • ALL's earnings are expected to decrease with -15.80% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y-15.8%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • ALL has a Yearly Dividend Yield of 2.13%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.63, ALL has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.80, ALL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.13%

5.2 History

  • On average, the dividend of ALL grows each year by 11.11%, which is quite nice.
  • ALL has paid a dividend for at least 10 years, which is a reliable track record.
  • ALL has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.11%
Div Incr Years14
Div Non Decr Years15
ALL Yearly Dividends per shareALL Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • ALL pays out 13.72% of its income as dividend. This is a sustainable payout ratio.
DP13.72%
EPS Next 2Y-15.8%
EPS Next 3YN/A
ALL Yearly Income VS Free CF VS DividendALL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B
ALL Dividend Payout.ALL Dividend Payout, showing the Payout Ratio.ALL Dividend Payout.PayoutRetained Earnings

ALLSTATE CORP

NYSE:ALL (2/26/2026, 12:46:50 PM)

211.55

+2.22 (+1.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners81.01%
Inst Owner Change1%
Ins Owners0.51%
Ins Owner Change-1.97%
Market Cap55.00B
Revenue(TTM)67.69B
Net Income(TTM)8.26B
Analysts77.14
Price Target245.31 (15.96%)
Short Float %2.44%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 2.13%
Yearly Dividend4.09
Dividend Growth(5Y)11.11%
DP13.72%
Div Incr Years14
Div Non Decr Years15
Ex-Date03-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)62.74%
Min EPS beat(2)46.62%
Max EPS beat(2)78.86%
EPS beat(4)4
Avg EPS beat(4)46.86%
Min EPS beat(4)20.62%
Max EPS beat(4)78.86%
EPS beat(8)8
Avg EPS beat(8)82.24%
EPS beat(12)11
Avg EPS beat(12)61.4%
EPS beat(16)12
Avg EPS beat(16)47.66%
Revenue beat(2)0
Avg Revenue beat(2)-1.72%
Min Revenue beat(2)-2.24%
Max Revenue beat(2)-1.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)2.27%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)3
Avg Revenue beat(12)0.82%
Revenue beat(16)7
Avg Revenue beat(16)4.69%
PT rev (1m)-0.17%
PT rev (3m)-0.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22.6%
EPS NY rev (1m)0.13%
EPS NY rev (3m)5.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 6.05
Fwd PE 8.61
P/S 0.82
P/FCF 6.37
P/OCF 6.23
P/B 2
P/tB 2.26
EV/EBITDA 6.12
EPS(TTM)34.95
EY16.52%
EPS(NY)24.58
Fwd EY11.62%
FCF(TTM)33.22
FCFY15.7%
OCF(TTM)33.95
OCFY16.05%
SpS257.1
BVpS105.79
TBVpS93.8
PEG (NY)N/A
PEG (5Y)0.32
Graham Number288.43
Profitability
Industry RankSector Rank
ROA 6.86%
ROE 30.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 14.27%
PM (TTM) 12.36%
GM N/A
FCFM 12.92%
ROA(3y)4.09%
ROA(5y)2.46%
ROE(3y)17.55%
ROE(5y)10.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-2.22%
PM growth 3YN/A
PM growth 5Y2.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 0.94
Debt/EBITDA 0.8
Cap/Depr 36%
Cap/Sales 0.28%
Interest Coverage 250
Cash Conversion 87.69%
Profit Quality 104.55%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.78%
EPS 3YN/A
EPS 5Y18.73%
EPS Q2Q%86.57%
EPS Next Y-29.66%
EPS Next 2Y-15.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.58%
Revenue growth 3Y9.6%
Revenue growth 5Y10.06%
Sales Q2Q%5.92%
Revenue Next Year5.73%
Revenue Next 2Y5.84%
Revenue Next 3Y8.67%
Revenue Next 5Y6.94%
EBIT growth 1Y69.63%
EBIT growth 3YN/A
EBIT growth 5Y7.62%
EBIT Next Year15.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.44%
OCF growth 3YN/A
OCF growth 5YN/A

ALLSTATE CORP / ALL FAQ

Can you provide the ChartMill fundamental rating for ALLSTATE CORP?

ChartMill assigns a fundamental rating of 4 / 10 to ALL.


Can you provide the valuation status for ALLSTATE CORP?

ChartMill assigns a valuation rating of 6 / 10 to ALLSTATE CORP (ALL). This can be considered as Fairly Valued.


Can you provide the profitability details for ALLSTATE CORP?

ALLSTATE CORP (ALL) has a profitability rating of 4 / 10.


Can you provide the financial health for ALL stock?

The financial health rating of ALLSTATE CORP (ALL) is 4 / 10.


What is the earnings growth outlook for ALLSTATE CORP?

The Earnings per Share (EPS) of ALLSTATE CORP (ALL) is expected to decline by -29.66% in the next year.